Device manufacturer, as written on reports
Siemens Healthcare Diagnostics - Glasgow: medical device reports filed with FDA
2,079 reports name it as the manufacturer of the device involved, 2010–2024.
- 2,079
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 98.7%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
2,079 medical device reports received by FDA give Siemens Healthcare Diagnostics - Glasgow as the manufacturer of the device involved, 0% of the MAUDE database, from November 2010 to March 2024. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (98.7%), other (0.3%) and injury (0.2%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Dimension Clinical Chemistry System | Immunoassay method, troponin subunit | 599 | 0 | 0.2% |
| Dimension R Clinical Chemistry System | Assay, glycosylated hemoglobin | 388 | 0 | 0% |
| Dimension Vista Urea Nitrogen Flex Reagent Cartridge | Urease and glutamic dehydrogenase, urea nitrogen | 217 | 0 | 0% |
| Dimension Vista R Clinical Chemistry System | Assay, glycosylated hemoglobin | 200 | 0 | 0% |
| Dimension Vista Clinical Chemistry System | Analyzer, chemistry (photometric, discrete), for clinical use | 156 | 0 | 0.2% |
| Stratus Cs | Immunoassay method, troponin subunit | 127 | 3 | 0% |
| Dimension Vista | Analyzer, chemistry (photometric, discrete), for clinical use | 91 | 8 | 0% |
| Dimension | Analyzer, chemistry (photometric, discrete), for clinical use | 74 | 40 | 0.1% |
| Stratus Cs Stat Fluorometric Analyzer | Immunoassay method, troponin subunit | 25 | 0 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| MMI | Immunoassay method, troponin subunit | 552 | 26.6% |
| LCP | Assay, glycosylated hemoglobin | 314 | 15.1% |
| CDQ | Urease and glutamic dehydrogenase, urea nitrogen | 229 | 11% |
| JGS | Electrode, ion specific, sodium | 226 | 10.9% |
| JIT | Calibrator, secondary | 60 | 2.9% |
| JLW | Radioimmunoassay, thyroid-stimulating hormone | 55 | 2.6% |
| JFY | Enzymatic method, creatinine | 53 | 2.5% |
| JJE | Analyzer, chemistry (photometric, discrete), for clinical use | 43 | 2.1% |
| DHA | System, test, human chorionic gonadotropin | 35 | 1.7% |
| KXT | Enzyme immunoassay, digoxin | 32 | 1.5% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Siemens Healthcare Diagnostics - Glasgow reports
How many FDA device reports name Siemens Healthcare Diagnostics - Glasgow as manufacturer?
2,079 reports through August 2026, 0 of them in the latest 12 months.
Which of its brands appear most often?
Dimension Clinical Chemistry System (599), Dimension R Clinical Chemistry System (388), Dimension Vista Urea Nitrogen Flex Reagent Cartridge (217), Dimension Vista R Clinical Chemistry System (200) and Dimension Vista Clinical Chemistry System (156).
Which device types does it report on?
immunoassay method, troponin subunit (26.6%), assay, glycosylated hemoglobin (15.1%), urease and glutamic dehydrogenase, urea nitrogen (11%) and electrode, ion specific, sodium (10.9%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.